Li et al. suggested that FGF21 may mirror the severity and progression of NAFLD due to its association with obesity, triglyceride, and gama-glutamyltransferase (Li et al., 2010). This evidence concerns the gene FGF21 and metabolic dysfunction-associated steatotic liver disease.